Biohaven Ltd.

BHVNNYSEUSD
12.49 USD
0.15 (1.25%)🟢PRE MARKET (AS OF 05:01 AM EDT)
🟢Market: OPEN

Biohaven Ltd. (BHVN) trades at $12.49 per share. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Sep 15, 2026.

Open?$12.35
High?$12.49
Low?$12.35
Prev. Close?$12.34
Volume?4
Avg. Volume?3.0M
VWAP?$12.37
Rel. Volume?0.00x
Bid / Ask
Bid?$12.25 × 100
Ask?$12.50 × 100
Spread?$0.25
Midpoint?$12.38
Valuation & Ratios
Market Cap?1.9B
Shares Out?151.0M
Float?119.4M
Float %?79.3%
P/E Ratio?N/A
P/B Ratio?152.50
EPS?-$3.89
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.
Employees
274
Market Cap
1.9B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2022-09-23
Address
215 CHURCH STREET
NEW HAVEN, CT 06510
Phone: 203-404-0410
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-1/3)
Medium-Term (Wave)? Bearish(-3/3)
Short-Term (Ripple)? Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
77
Short Sent.?
26
Piotroski F-Score?0/9Weak
Altman Z-Score?-10.06Distress
Confidence?49%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?15.92%High
Short Interest?19.0M
Days to Cover?4.8
Free Float119.4M
Avg Daily Volume4.0M
Settlement Date2026-08-31
Financial Health
Current Ratio?4.73Strong
Quick Ratio?4.73Strong
Cash Ratio?3.80Strong
Debt/Equity?21.23High
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A
P/B?
Peers
100
S&P
3
152.50HIGH
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
S&P
97
-3.4CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
S&P
3
-4,801.5%WEAK
ROA?
S&P
3
-158.3%WEAK
Cash Flow & Enterprise
FCF?$-511870000
Enterprise Value?$1.9B
Fundamentals ratios updated end of day